For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221024:nRSX7895Da&default-theme=true
RNS Number : 7895D Cellular Goods PLC 24 October 2022
The information contained within this announcement is deemed by the Company to
constitute inside information stipulated under the Market Abuse Regulation
(EU) No. 596/2014, as retained as part of the law of England and Wales. Upon
the publication of this announcement via the Regulatory Information Service,
this inside information is now considered to be in the public domain.
Press release
24 October 2022
Cellular Goods PLC
('Cellular Goods' or 'the Company')
Products launch on Debenhams.com
Cellular Goods (LSE: CBX), a UK-based wellness company providing premium
consumer products formulated with lab-produced cannabinoids, is pleased to
announce that its 'Look Better' (skincare) range will be available for
purchase on Debenhams' online premium marketplace, Debenhams.com, from today.
Cellular Goods will initially offer eight of its cannabinoid-based skincare
products on the online marketplace, making the Company the first cannabigerol
(CBG)-based skincare brand to offer its products on Debenhams.com and
contributing to Cellular Goods' efforts to continue building its sales
channels. With high numbers of monthly visitors to Debenhams.com, this
initiative will enable Cellular Goods to widen its reach and address demand
for products that can help prevent the signs of skin ageing and sensitivity.
The commencement of sales on Debenhams.com follows the launch of shipping to
the US, as well as the launch of Cellular Goods' four new gifting sets in the
Company's new 'Gift Better' (gifting) range, for the festive season, in
October.
Cellular Goods' products available on Debenhams.com include the new
Rejuvenating Night Cream, SPF 25 Rejuvenating Day Cream and Rejuvenating Day
Mousse, which contain the Company's proprietary formulation of cannabidiol
(CBD) and CBG. Other Cellular Goods products available on the Debenhams
marketplace include the Company's CBG-based Nourishing Cannabinoid Face Oil,
Calming Cannabinoid After Shaving Moisturiser and Rejuvenating Face Serum, as
well as all 'mini' sizes for all available 'Look Better' products.
Darcy Taylor, interim CEO of Cellular Goods, commented: "Debenhams is a
household name, with millions of people visiting its online marketplace every
month. By launching our products on the Debenhams ecommerce site, we are
taking another step in our efforts to continue increasing Cellular Goods'
visibility and expanding our sales channels. We are delighted that our
products are now available on Debehams.com and we are excited to be working
alongside them to help ensure their customers can more easily access our
products and take advantage of all their outstanding benefits."
For further information please contact:
Cellular Goods
Darcy Taylor via Tancredi +44 207 887 7633
Chairman
Neil Thapar +44 787 645 5323
Investor Relations
Tennyson Securities
Corporate Broker & Adviser
Peter Krens +44 207 186 9030
Alan Howard
Novum Securities
Corporate Broker
Colin Rowbury
Jon Belliss +44 207 399 9427
Tancredi Intelligent Communication
Media Relations
Helen Humphrey +44 744 922 6720
Gabriela Amaya Garcia +44 791 503 5294
Charlie Hobbs +44 789 755 7112
cellulargoods@tancredigroup.com (mailto:cellulargoods@tancredigroup.com)
About Cellular Goods PLC:
Cellular Goods is a UK-based wellness company that provides premium products
based on lab-made cannabinoids. It was established in August 2018 to develop
efficacy-led and research-backed cannabinoid-powered wellness products. The
initial focus is on three product verticals: Feel Better, Look Better and
Function Better. These three verticals encompass Cellular Goods' premium CBG
skincare and CBD wellness, with the first products launched in December 2021.
The Company's shares are listed on the main market of the London Stock
Exchange. www.cellular-goods.com (http://www.cellular-goods.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END PRLMJBATMTTTBLT